14-day Premium Trial Subscription Sign Up For FreeGet Free

ADMA Biologics Inc Stock Forecast NASDAQ:ADMA

$1.40 (7.69%)

Volume: 2M

Closed: Jan 14, 2022

Hollow Logo Score: 5.164

ADMA Biologics Inc Stock Forecast

$1.40 (7.69%)

Volume: 2M

Closed: Jan 14, 2022

Score Hollow Logo 5.164

ADMA Biologics Inc Stock Price (Quote) NASDAQ:ADMA

$1.40 ( 7.69% ) Friday, 14th Jan 2022

Range Low Price High Price Comment
30 days $1.17 $1.49 Friday, 14th Jan 2022 ADMA stock ended at $1.40. This is 7.69% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 9.15% from a day low at $1.28 to a day high of $1.40.
90 days $1.01 $1.68
52 weeks $1.01 $3.11

Historical ADMA Biologics Inc prices

Date Open High Low Close Volume
2022-01-14 $1.29 $1.40 $1.28 $1.40 2 201 704
2022-01-13 $1.26 $1.32 $1.26 $1.30 695 939
2022-01-12 $1.35 $1.36 $1.28 $1.28 703 365
2022-01-11 $1.34 $1.40 $1.34 $1.35 598 143
2022-01-10 $1.31 $1.36 $1.28 $1.34 946 501
2022-01-07 $1.29 $1.35 $1.29 $1.33 831 853
2022-01-06 $1.29 $1.34 $1.28 $1.31 793 000
2022-01-05 $1.45 $1.45 $1.29 $1.31 1 756 144
2022-01-04 $1.47 $1.49 $1.42 $1.43 1 754 811
2022-01-03 $1.40 $1.47 $1.36 $1.47 1 616 897
2021-12-31 $1.32 $1.42 $1.31 $1.41 2 551 620
2021-12-30 $1.31 $1.35 $1.29 $1.32 3 433 894
2021-12-29 $1.19 $1.32 $1.17 $1.30 3 493 386
2021-12-28 $1.24 $1.27 $1.18 $1.20 3 535 729
2021-12-27 $1.27 $1.28 $1.24 $1.25 1 189 428
2021-12-23 $1.26 $1.30 $1.25 $1.27 1 337 737
2021-12-22 $1.27 $1.32 $1.25 $1.29 1 864 445
2021-12-21 $1.35 $1.35 $1.25 $1.30 2 225 173
2021-12-20 $1.25 $1.30 $1.22 $1.30 1 341 759
2021-12-17 $1.19 $1.31 $1.17 $1.28 6 363 117
2021-12-16 $1.28 $1.31 $1.18 $1.20 2 722 781
2021-12-15 $1.27 $1.29 $1.21 $1.28 2 204 838
2021-12-14 $1.30 $1.34 $1.25 $1.27 2 123 900
2021-12-13 $1.33 $1.35 $1.26 $1.30 1 771 956
2021-12-10 $1.35 $1.39 $1.32 $1.33 1 151 750
2021-12-09 $1.40 $1.43 $1.33 $1.33 1 359 102
2021-12-08 $1.32 $1.40 $1.32 $1.38 1 484 945
2021-12-07 $1.31 $1.40 $1.30 $1.36 2 224 918
2021-12-06 $1.27 $1.31 $1.22 $1.28 1 801 292
2021-12-03 $1.36 $1.36 $1.27 $1.29 1 736 893
2021-12-02 $1.34 $1.38 $1.32 $1.36 1 290 739
2021-12-01 $1.39 $1.42 $1.32 $1.34 1 192 775
2021-11-30 $1.43 $1.45 $1.37 $1.38 1 377 785
2021-11-29 $1.45 $1.47 $1.41 $1.45 1 869 259
2021-11-26 $1.44 $1.46 $1.41 $1.45 837 141
2021-11-24 $1.40 $1.51 $1.37 $1.50 1 233 976
2021-11-23 $1.45 $1.46 $1.31 $1.41 1 838 664
2021-11-22 $1.53 $1.53 $1.44 $1.45 2 047 070
2021-11-19 $1.47 $1.54 $1.46 $1.53 2 488 391
2021-11-18 $1.48 $1.53 $1.45 $1.46 3 126 834
2021-11-17 $1.55 $1.56 $1.47 $1.50 1 864 599
2021-11-16 $1.51 $1.59 $1.48 $1.55 1 968 379
2021-11-15 $1.67 $1.67 $1.52 $1.55 3 956 206
2021-11-12 $1.61 $1.68 $1.58 $1.66 4 492 026
2021-11-11 $1.51 $1.65 $1.46 $1.59 12 784 963
2021-11-10 $1.42 $1.46 $1.37 $1.40 2 444 811
2021-11-09 $1.45 $1.47 $1.41 $1.42 2 154 618
2021-11-08 $1.35 $1.41 $1.34 $1.38 1 709 138
2021-11-05 $1.40 $1.40 $1.33 $1.36 1 170 534
2021-11-04 $1.48 $1.48 $1.37 $1.41 1 715 889

About ADMA Biologics Inc

ADMA Biologics ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate is RI-002, a plasma-derived, polyclonal immune globulin intravenous that is in Phase III clinical study for the treatment of primary immune deficiency disease. The company also operatesADMA BioCenters Georgia, Inc, which is a... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT